Reducing Allergic Manifestations in Children with Cow's Milk Allergy: Current Research

Roberto Berni Canani, MD, PhD, chief of the Pediatric Allergy Program in the Department of Translational Medicine, University of Naples, Italy, presents data from a trial of infants with cow's milk allergy (CMA). In Dr. Canani's trial, allergic manifestations during a 36-month trial of extensively hydrolyzed formula, with or without Lactobacillus rhamnosus GG, were determined in infants who had developed CMA between 1-12 months of age. Dr. Canani's research has implications for the treatment of cow's milk intolerance, and long-term outcomes for children who develop CMA, since substitutive formulas can be used to treat these patients.

Full credit for this course is earned by viewing the video as well as reflecting individually or discussing as a group the Additional Content for Discussion.

This course does not offer CE credit.

  • Roberto Berni Canani, MD, PhD

    Chief of the Pediatric Allergy Program
    Department of Translational Medicine
    University of Naples, Italy